• News
    • News by Region
      • College Station
      • Dallas/Fort Worth
      • El Paso
      • Galveston
      • Lubbock
      • San Antonio
      • Texas Cancer News: What You Need to Know
    • News by Topic
      • Alzheimer’s
      • Biofuels
      • Cancer
      • Cardiovascular
      • Diabetes
      • Genetics
      • Infectious Disease
      • Medical Device
      • Neurology
      • Vaccines
    • News by Institution
      • CPRIT
      • Baylor College of Medicine
      • Rice University
      • Texas A&M
      • Texas Heart Institute
      • UNT Health Science Center
      • UT Arlington
      • UT Austin
      • UT Dallas
      • UTHealth
      • UT MD Anderson Cancer Center
      • UT Medical Branch
      • UT Health Science Center San Antonio
      • University of Texas Southwestern Medical Center
    • Editorial Blog
  • Companies
    • Companies by City
      • Austin
        • Featured in Austin
      • College Station
      • Dallas
      • El Paso
      • Fort Worth
      • Galveston
      • Houston
        • Featured in Houston
      • Lubbock
      • San Antonio
      • Temple
      • Waco
    • Companies by Industry
      • Academic/Research
      • Biofuels
      • BioPharm Insurance
      • Biopharma
      • Biotech
      • Clinical Research
      • Contract Research
      • Cosmeceuticals
      • Diagnostics
      • Environmental
      • Featured
      • Genetics
      • Incubator/Accelerator
      • Legal
      • Manufacturing
      • Medical Devices
      • Pharmaceutical
      • Premium
      • Services
      • Supplements
      • Suppliers
      • Venture Capital
  • Service Providers
    • Services
      • Analytical Chemistry
      • Animal
      • Biochemistry
      • Bioprocess Contract
      • Biorepository
      • Cell Biology
      • Cell Culture
      • Chemistry
      • Clinical Research
      • Construction
      • Consulting
      • Contract Manufacturers
      • Contract Pharma
      • Contract Research
    • Suppliers
      • Biospecimens
      • Lab Equipment
      • Manufacturing
      • Meters
      • Microarrays
      • Microscopes
      • Miscellaneous
      • Molecular Biology
      • Packaging
      • Protein
      • Reagents
      • Research Tools
      • RNAi Technology
      • Safety & Hygiene
      • Sample Prep
      • Software Quality
      • Testing Systems
      • Vacuum Equipment
  • Channels
    • Regional Channels
      • Austin
      • College Station
      • Dallas / Fort Worth
      • El Paso
      • Galveston
      • Houston
      • Lubbock
      • San Antonio
    • Topic Channels
      • Alzheimer’s
      • Autism & Autism Spectrum Disorder: What You Need To Know
      • Autosomal Recessive Disease: What You Need To Know
      • Biofuels
      • Biomarkers: What You Need To Know
      • Biomaterials – Biospecimens
      • Brain Cancer: What You Need To Know
      • Cardiovascular
      • Chagas Disease: What You Need To Know
      • Cancer
      • Clostridium Difficile: What You Need To Know
      • Crohn’s Disease: What You Need To Know
      • Cystic Fibrosis: What You Need to Know
      • Dengue Fever: What You Need To Know
      • Depression
      • Ewing’s Sarcoma: What You Need To Know
      • Genetics
      • H7N9: What You Need To Know
      • Hepatitis B: What You Need To Know
      • Infectious Disease
      • Influenza: What You Need To Know
      • Leukemia: What You Need To Know
      • Liver Cancer: What You Need To Know
      • Lung Cancer: What You Need To Know
      • Medical Device
      • Myocardial Ischemia: What You Need To Know
      • Neglected Tropical Diseases: What You Need To Know
      • Neurology
      • Obesity: What You Need To Know
      • Peter Hotez: What You Need To Know
      • Prostate Cancer: What You Need To Know
      • Quantum Dots: What You Need To Know
      • Secondary Progressive MS: What You Need To Know
      • Spinal Muscular Atrophy: What You Need To Know
      • T-Cells: What You Need To Know
      • 3D Technology: What You Need To Know
      • Triple Negative Breast Cancer: What You Need To Know
      • West Nile Virus: What You Need To Know
  • About
  • Advertise

BioNews-TX

BioNews Texas

  • News
    • News by Region
      • College Station
      • Dallas/Fort Worth
      • El Paso
      • Galveston
      • Lubbock
      • San Antonio
      • Texas Cancer News: What You Need to Know
    • News by Topic
      • Alzheimer’s
      • Biofuels
      • Cancer
      • Cardiovascular
      • Diabetes
      • Genetics
      • Infectious Disease
      • Medical Device
      • Neurology
      • Vaccines
    • News by Institution
      • CPRIT
      • Baylor College of Medicine
      • Rice University
      • Texas A&M
      • Texas Heart Institute
      • UNT Health Science Center
      • UT Arlington
      • UT Austin
      • UT Dallas
      • UTHealth
      • UT MD Anderson Cancer Center
      • UT Medical Branch
      • UT Health Science Center San Antonio
      • University of Texas Southwestern Medical Center
    • Editorial Blog
  • Companies
    • Companies by City
      • Austin
        • Featured in Austin
      • College Station
      • Dallas
      • El Paso
      • Fort Worth
      • Galveston
      • Houston
        • Featured in Houston
      • Lubbock
      • San Antonio
      • Temple
      • Waco
    • Companies by Industry
      • Academic/Research
      • Biofuels
      • BioPharm Insurance
      • Biopharma
      • Biotech
      • Clinical Research
      • Contract Research
      • Cosmeceuticals
      • Diagnostics
      • Environmental
      • Featured
      • Genetics
      • Incubator/Accelerator
      • Legal
      • Manufacturing
      • Medical Devices
      • Pharmaceutical
      • Premium
      • Services
      • Supplements
      • Suppliers
      • Venture Capital
  • Service Providers
    • Services
      • Analytical Chemistry
      • Animal
      • Biochemistry
      • Bioprocess Contract
      • Biorepository
      • Cell Biology
      • Cell Culture
      • Chemistry
      • Clinical Research
      • Construction
      • Consulting
      • Contract Manufacturers
      • Contract Pharma
      • Contract Research
    • Suppliers
      • Biospecimens
      • Lab Equipment
      • Manufacturing
      • Meters
      • Microarrays
      • Microscopes
      • Miscellaneous
      • Molecular Biology
      • Packaging
      • Protein
      • Reagents
      • Research Tools
      • RNAi Technology
      • Safety & Hygiene
      • Sample Prep
      • Software Quality
      • Testing Systems
      • Vacuum Equipment
  • Channels
    • Regional Channels
      • Austin
      • College Station
      • Dallas / Fort Worth
      • El Paso
      • Galveston
      • Houston
      • Lubbock
      • San Antonio
    • Topic Channels
      • Alzheimer’s
      • Autism & Autism Spectrum Disorder: What You Need To Know
      • Autosomal Recessive Disease: What You Need To Know
      • Biofuels
      • Biomarkers: What You Need To Know
      • Biomaterials – Biospecimens
      • Brain Cancer: What You Need To Know
      • Cardiovascular
      • Chagas Disease: What You Need To Know
      • Cancer
      • Clostridium Difficile: What You Need To Know
      • Crohn’s Disease: What You Need To Know
      • Cystic Fibrosis: What You Need to Know
      • Dengue Fever: What You Need To Know
      • Depression
      • Ewing’s Sarcoma: What You Need To Know
      • Genetics
      • H7N9: What You Need To Know
      • Hepatitis B: What You Need To Know
      • Infectious Disease
      • Influenza: What You Need To Know
      • Leukemia: What You Need To Know
      • Liver Cancer: What You Need To Know
      • Lung Cancer: What You Need To Know
      • Medical Device
      • Myocardial Ischemia: What You Need To Know
      • Neglected Tropical Diseases: What You Need To Know
      • Neurology
      • Obesity: What You Need To Know
      • Peter Hotez: What You Need To Know
      • Prostate Cancer: What You Need To Know
      • Quantum Dots: What You Need To Know
      • Secondary Progressive MS: What You Need To Know
      • Spinal Muscular Atrophy: What You Need To Know
      • T-Cells: What You Need To Know
      • 3D Technology: What You Need To Know
      • Triple Negative Breast Cancer: What You Need To Know
      • West Nile Virus: What You Need To Know
  • About
  • Advertise
  • Follow
    • Facebook
    • Twitter
    • Google+
    • Linkedin
    • Pinterest
Positive Trial Results For VGXI’s Aerosol Gene Therapy Announced by UK Cystic Fibrosis Gene Therapy Consortium
Home
News

Positive Trial Results For VGXI’s Aerosol Gene Therapy Announced by UK Cystic Fibrosis Gene Therapy Consortium

July 13th, 2015 Anna Tan, RN 0 comments

The United Kingdom Cystic Fibrosis Gene Therapy Consortium (UKCFGTC) recently published the first findings from Phase IIb multi-dose clinical study on cystic fibrosis. In this study, CF patients were treated with aerosolized DNA plasmid expressing Cystic Fibrosis Transmembrane Conductance Receptor (CFTR), developed at Woodlands, Texas-based VGXI‘s cGMP facility, making this study a pioneer in showing gene therapy can produce significant improvement on CF and lung function.

“One hundred and thirty-six patients aged 12 and above received monthly, inhaled doses of the gene therapy or a placebo for 1 year,” said Professor Deborah Gill, from Oxford University. “The results are encouraging and are expected to lead to a further study to assess higher, more frequent doses.”

VGXI, a leading provider of plasmid DNA manufacturing and development services for DNA vaccine and gene therapy research, is determined to maintain its impressive track record of successful plasmid products manufactured under GMP conditions, and is proud to have been an active team player in the UKCFGTC’s translational program for the past 10 years.

“We are delighted that the UKCFGTC has continued to trust in VGXI’s manufacturing capabilities,” said Mr. Young Park, President and CEO of VGXI. “The entire VGXI team is committed to providing the highest quality DNA products and services, and it is rewarding to see these products make a meaningful impact on patients’ quality of life.”

The two companies have been working on CFTR plasmid product development since 2005. Through their collaboration, VGXI’s expert scientists have significantly boosted production yields through plasmid re-design and optimization of the fermentation and recovery process. The company is committed to providing UKCFGTC large-scale manufacturing support as its clinical trials advance to later stages.

In an earlier report on cystic fibrosis, the FDA recently announced the approval of a new therapy that treats Cystic Fibrosis (CF). The drug, called Orkambi, is manufactured by Boston-based Vertex Pharmaceuticals Inc. and treats the underlying cause of the disease in patients who have two copies of a certain mutation.

Access more daily updates on cystic fibrosis by visiting and subscribing to http://cysticfibrosisnewstoday.com.

Share this article

Next article Sean P. Nolan Appointed AveXis Chief Executive Officer
Previous article Harold C. Simmons Cancer Center First to Receive NCI Designation in North Texas

Anna Tan, RN

Anna is responsible for the scripting and production of video news content. Her skills as a registered nurse as well as a proven video content creator on YouTube and other social media platforms allow her to create video news reports that are engaging and easy to understand for patients.

Popular Tags

20th annual Vulcan Materials Funshoot 340B 2014 World Stem Cell Summit austin BIG DATA bioaustin biorepositories biospecimens blog Cancer Therapy & Research Center Chemistry Chuck Reed College Station CPRIT CPRIT Foundation crowdfunding cystic fibrosis Dallas DFW drug discount enventure fort worth Funding Galveston GlaxoSmithKline Governor Rick Perry Greatbatch Greg Abbott Health Industry Council of North Texas houston How to Support People With MS Jennifer Stevens lab Medical Device Multiple Sclerosis Multiple Sclerosis Support Obama Obamacare Primary Progressive Multiple Sclerosis san antonio Sante Ventures SB 149 Signs Of MS Texas A&M thbi

Archives

  • Texas’ Only Source For Biotech & Life Sciences News
  • About
  • News
  • Terms of Use
  • Privacy Policy
  • Contact
  • Back to top
© BioNews Services
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more